Related Experiment Videos
Orphan G protein-coupled receptors and beyond
1Laboratory of Pharmacology, College of Pharmacy, Pusan National University, Pusan, Republic of Korea. imds@pusan.ac.kr
Japanese Journal of Pharmacology
|November 7, 2002
Summary
Researchers are exploring orphan receptors, identified through the Human Genome Project, to discover new natural ligands. This review covers recent ligand discoveries and strategies for orphan receptor analysis, paving the way for reverse pharmacology advancements.
Area of Science:
- Pharmacology
- Genomics
- Molecular Biology
Background:
- G protein-coupled receptors (GPCRs) for known ligands have been extensively cloned using techniques like PCR.
- The pool of known ligands is nearly exhausted, limiting further GPCR discovery.
- The Human Genome Project has identified numerous orphan receptors with unknown natural ligands.
Purpose of the Study:
- To review recent advancements in the discovery of natural ligands for receptors.
- To describe effective strategies for analyzing orphan receptors.
- To predict future directions in the field of reverse pharmacology.
Main Methods:
- Review of existing literature on GPCRs and ligand discovery.
- Analysis of techniques used for identifying natural ligands.
- Discussion of strategies for characterizing orphan receptors.
Main Results:
- Significant progress has been made in identifying natural ligands for previously unknown receptors.
- Various strategies are proving effective in the analysis of orphan receptors.
- The field is moving towards a new era of reverse pharmacology.
Conclusions:
- Orphan receptors represent a vast, untapped resource for discovering novel biological pathways and therapeutic targets.
- Continued research into orphan receptors and their ligands is crucial for advancing pharmacological understanding.
- Reverse pharmacology offers a promising approach to drug discovery by starting with receptor identification.